In summary: Leading InnovationRx highlights a series of significantaclea health policy developments including Medicaid cuts, drug development bias in AI, BiTech and Pharma collaborations, and the FDA’s decisions on COVID-19 vaccines. These developments underscore the need for collaboration, innovation, and robust infrastructure to address health challenges and ensure equitable healthcare.
